Allergan
Allergan
Allergan plc is a global pharmaceutical company specializing in aesthetics, eye care, neurosciences, and gastrointestinal treatments.
Overview
Founded as a small eye care company, Allergan has since grown into a multifaceted pharmaceutical giant, known especially for its product Botox.
History
- 1948: Allergan was founded by Gavin S. Herbert to produce nose drops and an anti-allergy medication in Los Angeles.
- 1950s: The company expanded into eye care products, launching its first blockbuster drug, an eye drop.
- 1980s-1990s: Allergan expanded globally, establishing its presence in over 100 countries.
- 2015: Allergan was acquired by Actavis plc, which then adopted the name Allergan.
- 2020: AbbVie acquired Allergan in a deal worth approximately $63 billion.
Notable Products
- Botox (onabotulinumtoxinA): A neurotoxin used for various cosmetic and therapeutic treatments.
- Restasis: A medication used to increase tear production in people with dry eyes.
- Juvederm: A range of injectable dermal fillers.
- CoolSculpting: A non-surgical body contouring treatment.
Research and Development
Allergan has been at the forefront of R&D in its specialized fields, with a focus on patient-centric innovation. Its R&D centers globally collaborate on drug discovery and development.
Corporate Social Responsibility
Allergan has committed itself to sustainability, patient welfare, and community service. Their initiatives include patient assistance programs, donations, and environmental sustainability practices.
Controversies
Allergan has faced its share of controversies, especially related to drug pricing, patents, and FDA regulations.
Facilities
With its global presence, Allergan has R&D, manufacturing, and commercial operations located in various regions around the world.
See Also
References
- [1] "Allergan: Our History". Allergan Official Website.
- [2] "The Evolution of Allergan". Pharmaceutical Executive Magazine.
- [3] "AbbVie Completes Acquisition of Allergan". Reuters.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen
